XTX Topco’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $391K | Sell |
41,639
-39,258
| -49% | -$368K | 0.02% | 1273 |
|
|
2025
Q1 | $575K | Buy |
80,897
+36,989
| +84% | +$263K | 0.03% | 924 |
|
|
2024
Q4 | $512K | Buy |
43,908
+29,006
| +195% | +$338K | 0.04% | 745 |
|
|
2024
Q3 | $306K | Sell |
14,902
-35,562
| -70% | -$731K | 0.02% | 1162 |
|
|
2024
Q2 | $1.13M | Buy |
50,464
+32,201
| +176% | +$721K | 0.1% | 311 |
|
|
2024
Q1 | $502K | Buy |
18,263
+5,642
| +45% | +$155K | 0.07% | 484 |
|
|
2023
Q4 | $385K | Sell |
12,621
-2,255
| -15% | -$68.8K | 0.08% | 428 |
|
|
2023
Q3 | $470K | Buy |
+14,876
| New | +$470K | 0.08% | 439 |
|
|
2023
Q2 | – | Sell |
-13,258
| Closed | -$494K | – | 1701 |
|
|
2023
Q1 | $494K | Buy |
13,258
+55
| +0.4% | +$2.05K | 0.1% | 300 |
|
|
2022
Q4 | $461K | Buy |
13,203
+1,796
| +16% | +$62.7K | 0.1% | 340 |
|
|
2022
Q3 | $638K | Buy |
+11,407
| New | +$638K | 0.16% | 147 |
|
|
2021
Q3 | – | Sell |
-2,762
| Closed | -$447K | – | 945 |
|
|
2021
Q2 | $447K | Buy |
+2,762
| New | +$447K | 0.15% | 218 |
|